New interest in hair thinning is climbing alongside the popularity of GLP-1 weight-loss drugs. As searches regarding Wegovy-related shedding increase, the beauty market is shifting to meet this demand.
A 450% spike in Wegovy-related hair loss searches
The rapid rise of GLP-1 medications is creating a secondary market for hair health. According to social media-tracking analyst Spate, there have been 302,000 Google searches related to GLP-1 hair thinning over the last year, representing a nearly 58% increase year-on-year.
Specific concerns about medication side effects are driving this digital conversation. Google data provided by Boots shows that searches for "Does Wegovy cause hair loss?" have surged by 450%, while searches for "Mounjaro hair loss" have more than doubled in the same period. While the shedding associated with rapid weight loss is often temporary,the sheer volume of users is creating a massive, new cohort of consumers looking for ways to protect their hair density.
Why 22% of women are now more likely to use hair loss products than men
The hair loss category is undergoing a major demographic shift, moving away from its historical focus on male-pattern baldness. McKinsey research involving 15,000 consumers across 13 countries reveals that women are now more likely to use hair loss products than men, with 22% of women using them compared to 16% of men.
This shift is being fueled by a wider range of triggers beyond genetics. As noted in the report, consumers are increasingly seeking solutions for perimenopause, postpartum shedding, stress, and nutritional deficiencies. This evolution is turning hair loss from a niche medical concern into a mainstream wellness category that encompasses "hair longevity" and scalp health.
How Cult Beauty and Boots are seeing a 30% jump in scalpcare sales
Retailers are already capitalizing on the "skinification" of hair,where the scalp is treated with the same intensity as facial skin. Online retailer Cult Beauty has reported a 30% increase in sales within its hair loss and thinning category over the past year,while Boots has seen a similar 30% uptick in scalpcare products.
The demand for high-performance ingredients is driving specific brand successes. At Cult Beauty, sales of scalp treatments have jumped 147% year-on-year, and the K18 FutureIQ Biomimetic Hair Longevity Serum has already surpassed launch targets. Meanwhile, Beyoncé’s Cécred label has seen significant momentum, with its density serum becoming a top seller at Ulta. Even high-tech solutions are seeing traction, such as Currentbody’s LED Hair Growth Helmet, which reportedly generated approximately $539,000 from 627 units in the US in just one month.
The uncertainty of whether serums can actually trigger new growth
Despite the influx of new products, significant questions remain regarding the efficacy of the current market. While many brands use the language of "hair longevity" and "scalp health," it remains unverified whether these topical treatments can truly stimulate new follicle growth or if they are simply providing cosmetic improvements to existing hair. The report highlights that hair loss is not a singular diagnosis, and what works for one person may not work for another.
Trichologist Hannah Gaboardi notes that because hair loss can be caused by anything from hormonal changes to rapid weight loss, understanding the root cause is essential for effective treatment. This creates a challenge for brands: they must prove they are offering science-backed solutions rather than just borrowing clinical language to capitalize on a passing trend.
Comments 0